Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119616) titled 'Application of DNA methylation markers in endometrial cancer screening' on March 1.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University School of Medicine
Condition:
endometrial cancer
Intervention:
Gold Standard:Endometrial biopsy histopathology
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Target condition:2000;Difficult condition:400
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.h...